US3879549A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Treatment of bilharziosis and filariasis employing the antimony salt of certain hydroxy quinolines
Assignee: Individual
•
Filing: 1973-07-25
•
Granted: 1975-04-22
•
Expires: 1993-07-25
Abstract
Abstract A process for the treatment of bilharziosis or filariasis in human beings which comprises adminstering orally to a human being the antimony salt of 8-hydroxyquinoline, 6-methyl-8hydroxyquinoline, 5-fluoro-8-hydroxyquinoline, 5-chloro-8hydroxyquinoline, 5-nitro-8-hydroxyquinoline, 5-sulpho-8hydroxyquinoline, 5-chloro-7-iodo-8-hydroxyquinoline, 5,7dibramo-8-hydroxyquinoline, 5-chloro-7-iodo-6-methyl-8hydroxyquinoline, or 5,7-dibromo-6-methyl-8-hydroxyquinoline, at a daily dose of 60 to 100 mg of the salt per day.
Inventors
- 👤 Eugene Riviere
- 👤 Danyele Yvette Vilarel
- 👤 Roger Lucien Debrie
- 👤 Gerald Paul Marie Henr Loiseau
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 22:39
CPC Classifications
C; C07; C07F; C07F9/00; C07F9/90; C07F9/902; C07D; C07D215/00; C07D215/02; C07D215/16; C07D215/20; C07D215/24; C07D215/26; C07D215/30
Claims Analysis
Total Claims: 2
Claim 1
Independent Claim
58 words
A PROCESS FOR THE TREATMENT OF BILHARZIOSIS OR FILARIASIS IN HUMAN BEINGS WHICH COMPRISES ADMINISTERING ORALLY TO A HUMAN BEING IN NEED OF SUCH TREATMENT AN EFFECTIVE AMOUNT OF THE ANTIMONY SALT OF 8-HYDROXYQUINOLINE, 6-METHYL-8HYDROXYQUINPLINE, 5-FLUORO-8-HYDROXYQUINOLINE, 5-CHLORO-8HYDROXYQUINOLINE, 5-NITRO-8-HYDROXYQUINOLINE, 5-SULPHO-8HYDROXYQUINOLINE, 5-CHLORO-7-IODO-8-HYDROXYQUINOLINE, 5,7DIBROMO-8-HYDROXYQUINOLINE, 5-CHLORO-7-IODO-6-METHYL-8HYDROXYQUINOLINE, OR 5,7-DIBROMO-6-METHYL:8HYDROXYQUINOLINE, AT A DAILY DOSE OF 60 TO 100 MG OF THE SALT PER DAY.
Claim 2
Dependent Claim
58 words
A PROCESS FOR THE TREATMENT OF BILHARZIOSIS OR FILARIASIS IN HUMAN BEINGS WHICH COMPRISES ADMINISTERING ORALLY TO A HUMAN BEING IN NEED OF SUCH TREATMENT AN EFFECTIVE AMOUNT OF THE ANTIMONY SALT OF 8-HYDROXYQUINOLINE, 6-METHYL-8HYDROXYQUINPLINE, 5-FLUORO-8-HYDROXYQUINOLINE, 5-CHLORO-8HYDROXYQUINOLINE, 5-NITRO-8-HYDROXYQUINOLINE, 5-SULPHO-8HYDROXYQUINOLINE, 5-CHLORO-7-IODO-8-HYDROXYQUINOLINE, 5,7DIBROMO-8-HYDROXYQUINOLINE, 5-CHLORO-7-IODO-6-METHYL-8HYDROXYQUINOLINE, OR 5,7-DIBROMO-6-METHYL:8HYDROXYQUINOLINE, AT A DAILY DOSE OF 60 TO 100 MG OF THE SALT PER DAY.
References Cited (Backward Citations)
US2608556A
Cited
US3287210A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1978-04-21 | 1978-10-21 | 1979-04-22 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1982-04-21 | 1982-10-21 | 1983-04-22 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1986-04-21 | 1986-10-21 | 1987-04-22 | $7700.00 | Window Closed / Lapsed |